New combo therapy aims to shrink tough lung tumors
NCT ID NCT06623136
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding an experimental drug (ES102) to an approved immunotherapy (toripalimab) can shrink tumors in people with advanced non-small cell lung cancer that has not responded to prior treatment. About 40 adults aged 18-75 will receive the combination and be monitored for tumor response and side effects. The goal is to improve disease control, not to cure the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL-CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Chest Hospital, Capital Medical University
RECRUITINGBeijing, Beijing Municipality, China
Contact
Contact
-
Cancer Hospital of Shandong First Medical University (Shandong Cancer Institute, Shandong Cancer Hospital)
NOT_YET_RECRUITINGJinan, Shandong, China
Contact
Contact
-
Henan Cancer Hospital
RECRUITINGZhengzhou, Henan, China
Contact Phone: •••-•••-••••
Contact
-
Jilin Cancer Hospital
RECRUITINGChangchun, Jilin, China
Contact
Contact
-
Shanxi Provincial Cancer Hospital
RECRUITINGTaiyuan, China
Contact
Contact
-
Taizhou Hospital
RECRUITINGTaizhou, China
Contact
Contact
-
The First Affiliated Hospital of He'nan University of Science and Technology
RECRUITINGLuoyang, China
Contact
Contact
-
The First Affiliated Hospital of Nanchang University
NOT_YET_RECRUITINGNanchang, Jiangxi, China
Contact
Contact
-
The First Affiliated Hospital of Zhengzhou University
RECRUITINGZhengzhou, Henan, China
Contact
Contact